Franklin Resources Inc. Has $750,000 Stock Holdings in USANA Health Sciences, Inc. (NYSE:USNA)

Franklin Resources Inc. raised its holdings in USANA Health Sciences, Inc. (NYSE:USNAFree Report) by 9.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,050 shares of the company’s stock after purchasing an additional 1,771 shares during the period. Franklin Resources Inc. owned approximately 0.11% of USANA Health Sciences worth $750,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. American Century Companies Inc. lifted its stake in USANA Health Sciences by 12.3% in the 2nd quarter. American Century Companies Inc. now owns 159,782 shares of the company’s stock valued at $7,229,000 after purchasing an additional 17,460 shares during the last quarter. Assenagon Asset Management S.A. lifted its position in shares of USANA Health Sciences by 13.5% during the 3rd quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock valued at $4,702,000 after acquiring an additional 14,756 shares during the period. Allspring Global Investments Holdings LLC boosted its holdings in USANA Health Sciences by 14,068.2% in the third quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock worth $1,472,000 after acquiring an additional 38,547 shares in the last quarter. Pzena Investment Management LLC grew its holdings in shares of USANA Health Sciences by 24.4% during the second quarter. Pzena Investment Management LLC now owns 976,633 shares of the company’s stock valued at $44,183,000 after buying an additional 191,289 shares during the last quarter. Finally, Deerfield Management Company L.P. Series C grew its holdings in USANA Health Sciences by 297.0% during the second quarter. Deerfield Management Company L.P. Series C now owns 29,742 shares of the company’s stock worth $1,346,000 after buying an additional 22,251 shares in the last quarter. Institutional investors and hedge funds own 54.25% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. StockNews.com raised USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Saturday. DA Davidson upgraded shares of USANA Health Sciences to a “hold” rating in a research report on Friday, December 20th.

Get Our Latest Stock Analysis on USNA

USANA Health Sciences Stock Down 0.7 %

Shares of NYSE USNA opened at $35.69 on Monday. The company has a market cap of $680.25 million, a price-to-earnings ratio of 12.61, a PEG ratio of 1.25 and a beta of 0.89. USANA Health Sciences, Inc. has a 52 week low of $31.44 and a 52 week high of $54.81. The firm’s fifty day moving average is $37.88 and its 200 day moving average is $39.89.

USANA Health Sciences (NYSE:USNAGet Free Report) last released its earnings results on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, beating analysts’ consensus estimates of $0.49 by $0.07. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The company had revenue of $200.22 million during the quarter, compared to analysts’ expectations of $208.45 million. During the same quarter last year, the business posted $0.59 EPS. Equities research analysts anticipate that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Insider Activity at USANA Health Sciences

In other news, Director Gilbert A. Fuller sold 675 shares of the firm’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $37.71, for a total transaction of $25,454.25. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.33% of the stock is currently owned by insiders.

USANA Health Sciences Company Profile

(Free Report)

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.

Featured Stories

Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNAFree Report).

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.